Immunovant Inc. (IMVT)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 859 |
| % of all portfolios: | 0.001% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2026 | |||||
| ≡ | David Einhorn - Greenlight Capital | Buy | 93,520 | 0.07 | |
| Q2 2025 | |||||
| ≡ | Viking Global Investors | Sell 100.00% | 1,114,827 | 0.06 | |
| Q1 2025 | |||||
| ≡ | Viking Global Investors | Reduce 20.78% | 292,463 | 0.02 | |
| Q4 2024 | |||||
| ≡ | Viking Global Investors | Reduce 39.36% | 913,612 | 0.07 | |
| Q2 2024 | |||||
| ≡ | Viking Global Investors | Add 28.29% | 511,730 | 0.05 | |
| Q1 2024 | |||||
| ≡ | Viking Global Investors | Buy | 1,809,172 | 0.22 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.